Rituximab in the management of refractory myasthenia gravis-Reference-Cited by-同舟云学术

Rituximab in the management of refractory myasthenia gravis

Published:2010-03 Issue:3 Volume:41 Page:375-378
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Zebardast Nazlee,Patwa Huned S.,Novella Steven P.,Goldstein Jonathan M.

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Reference17 articles.

1. Steroids and immunosuppressant drugs in myasthenia gravis;Sathasivam;Nat Clin Pract Neurol,2008

2. Inhibition of B cell functions: implications for neurology;Dalakas;Neurology,2008

3. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab;Boye;Ann Oncol,2003

4. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma;Gajra;Am J Hematol,2004

5. Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis;Baek;J Neurol Neurosurg Psychiatry,2007

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysis;Frontiers in Neurology;2023-12-28

2. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

3. Childhood myasthenia gravis in Japan: Pathophysiology and treatment options;Clinical and Experimental Neuroimmunology;2023-07-19

4. Neuropharmacology in the Intensive Care Unit;Critical Care Clinics;2023-01

5. The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study;Annals of Indian Academy of Neurology;2023